Unable to construct genuine nanoassemblers, Xymos was using bacteria to crank out their molecules. This was genetic engineering, not nanotechnology.
Xymos faced challenges in developing authentic nanoassemblers and turned to bacteria to produce molecules instead. Their approach relied on genetic engineering rather than the anticipated nanotechnology. This shift in methodology highlights the limitations in achieving their original goal of constructing nanoassemblers.
This scenario emphasizes the intersection between biology and technology, demonstrating that when one avenue proves difficult, scientists may adapt by harnessing living organisms. While Xymos initially aimed for a breakthrough in nanotechnology, their reliance on genetic engineering showcases the flexibility and resourcefulness required in scientific exploration.
